Clinical Trial: A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide Medication

U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07855133) titled 'A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide Medication' on Sept. 28.

Brief Summary: The purpose of this clinical study is to find out which zenagamtide dose can be switched to, from maintenance dose of semaglutide in people with overweight or obesity, with or without type 2 diabetes (T2D). All participants will get semaglutide and zenagamtide.

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Overweight Obesity Type 2 Diabetes

Intervention: DRUG: Semaglutide

Semaglutide wi...